Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Meropenem (1000mg) + Sulbactam (500mg)
Therapeutic Category
Antibacterials, Antibiotic
Dosage Form
Injection
Packaging Type
Vial
Packaging
1.5gm
Price
₹2890/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Merotyle 1.5 GM Injection is a combination of Meropenem, a broad-spectrum carbapenem antibiotic, and Sulbactam, a beta-lactamase inhibitor. This synergistic combination enhances the antibiotic's ability to combat resistant bacterial strains by protecting Meropenem from degradation by beta-lactamase enzymes produced by certain bacteria. The result is a highly effective treatment against severe and multi-drug-resistant bacterial infections.
This injection is used to treat serious infections such as pneumonia, intra-abdominal infections, complicated urinary tract infections, skin and soft tissue infections, and bacterial meningitis. The addition of Sulbactam extends the coverage against beta-lactamase-producing bacteria, making it suitable for treating infections caused by resistant pathogens.
Common side effects include headache, nausea, vomiting, diarrhea, injection site reactions, and rash. Rarely, allergic reactions, seizures, or elevated liver enzymes may occur. Consult a doctor if severe or persistent side effects develop.
Used to treat severe bacterial infections, including resistant strains in respiratory, abdominal, and skin infections.
This medication is for intravenous use and should be administered by qualified healthcare professionals. Avoid use in patients with known hypersensitivity to carbapenems or beta-lactam antibiotics. Seek immediate medical attention if allergic reactions occur.
Store below 25°C in a cool, dry place away from light. After reconstitution, use immediately or as advised by a healthcare professional.
Composition : Meropenem (1000mg) Injection
Composition : Meropenem (250mg)
Composition : Meropenem (500mg) Injection
Composition : Amikacin (100mg)
Composition : Amikacin (250mg)
Composition : Amikacin (500mg)
Composition : Vancomycin (1000mg) Injection
Composition : Vancomycin (500mg) Injection
Composition : Amoxycillin (250mg) + Clavulanic Acid (50mg)
Composition : Amoxycillin (125mg) + Clavulanic Acid (25mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Meropenem 1000 mg + Sulbactam 500 mg Injection is a powerful broad-spectrum antibiotic combination used for severe and resistant bacterial infections such as pneumonia, sepsis, intra-abdominal infections, complicated urinary tract infections, and hospital-acquired infections. It is a high-end critical-care injectable product widely used in ICUs, emergency wards, and tertiary care hospitals. It is a strong anti-infective and hospital segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from strong institutional demand from hospitals, ICUs, and surgical departments. Combination antibiotics like meropenem + sulbactam are commonly included in hospital protocols for resistant infections, ensuring consistent bulk procurement and repeat institutional orders.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in critical-care, injectable antibiotic, and hospital segment formulations with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and institutional suppliers benefit from high-value hospital orders, ICU-driven demand, and continuous usage in resistant infection management protocols, making it a strong and stable pharmaceutical segment when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in critical-care antibiotic injectables can contact Cafoli Lifecare to discuss hospital supply terms, product availability, and PCD pharma franchise opportunities in the anti-infective injectable segment.